Sono-Tek (SOTK) Q1 2025 earnings summary

Executive summary

• Net sales rose 40% year-over-year to $5.03M, driven by strong shipments to Medical and Alternative/Clean Energy markets.

• Net income surged to $331K from $53K, reflecting higher sales and investment income, and EPS increased to $0.02.

• Operating income improved to $238K from a loss of $92K in the prior year quarter.

• 39% of sales were generated outside the US and Canada, up from 34% a year ago.

• Cash, cash equivalents, and marketable securities totaled $12.2M with no outstanding debt.

Financial highlights

• Gross profit increased 38% to $2.45M; gross margin slightly decreased to 48.8% due to product mix and cost realignment.

• Operating margin improved to 4.7% from -2.6% year-over-year.

• Net margin rose to 6.6% from 1.5% in the prior year period.

• Equipment backlog at quarter-end was $7.69M, down 15.4% sequentially; combined backlog was $7.83M, down 16%.

• Working capital increased to $12.49M from $12.12M at prior year-end.

Outlook and guidance

• Management anticipates continued sales growth in medical and alternative energy markets, with expectations for a rebound in industrial market sales in Q2 FY2025.

• Sales growth guidance for Q2 FY2025 is 2–5% above Q1 FY2025, with continued growth expected for the full fiscal year.

• Revenue variability is expected due to large, high-ASP machine orders and evolving product mix.

• Anticipates increasing orders in green energy systems and strength in medical device and semiconductor/electronics markets.